Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,455 | -17,298 | -12,000 | -5,600 | -3,705 |
| Income taxes - deferred | -859 | -1,088 | -1,088 | N/A | N/A |
| Other Working Capital | 837 | -404 | -424 | 151 | 567 |
| Other Operating Activity | 11,989 | 8,222 | 5,985 | 43 | 988 |
| Operating Cash Flow | $-2,488 | $-10,568 | $-7,527 | $-5,406 | $-2,150 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 2,099 | 2,099 | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | -455 | N/A |
| Common Stock Issued | 188 | 12,124 | 6,242 | 363 | 1,557 |
| Other Financing Activity | -135 | -1,052 | -930 | 5,606 | 576 |
| Financing Cash Flow | $53 | $13,171 | $7,411 | $5,514 | $2,133 |
| Exchange Rate Effect | N/A | 1 | 1 | 4 | N/A |
| Beginning Cash Position | 5,263 | 2,659 | 2,659 | 2,659 | 2,659 |
| End Cash Position | 2,828 | 5,263 | 2,544 | 2,771 | 2,642 |
| Net Cash Flow | $-2,435 | $2,604 | $-115 | $112 | $-17 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,488 | -10,568 | -7,527 | -5,406 | -2,150 |
| Free Cash Flow | -2,488 | -10,568 | -7,527 | -5,406 | -2,150 |